AMAG Pharma (AMAG) Misses Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AMAG Pharmaceuticals Reports Record Second Quarter 2015 Financial Results
July 23, 2015 7:01 AM EDTAchieves quarterly net product sales of $84.7 million and Non-GAAP adjusted EBITDA of $52.1 million
Executes on two business development initiatives to further expand maternal health business
Increases Non-GAAP Adjusted EBITDA and cash earnings guidance for 2015
Conference call scheduled for 8:00 a.m. ET today
WALTHAM, Mass., July 23, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a specialty pharmaceutical company, today reported unaudited consolidated financial results for the second quarter and year-to-date periods ended June 30, 2015. Total revenues for the second quarter of... More
